* Patients can try NITYR for 30 days, one time, for free, as long as their doctor prescribes it. Subject to terms and conditions, eligibility criteria, and other federal and state law. Terms and Conditions and eligibility criteria are available at www.nityr.us/offerstcs

See offer Consultation Guide
See offer Consultation Guide
+
This site is intended for US healthcare providers NITYR Back to top
NITYR Enrollment Form Safety InformationPrescribing Information
Safety InformationPrescribing Information

News

New Nutrition Support Launched to Benefit HCPs and NITYR patients

Low Protein Recipes

Sign up for updates

Please click the button below and fill out the form to sign up to updates from our newsletter.

Sign up

US FDA GRANTS ONCE DAILY DOSING OPTION FOR NITYR (NITISINONE) TABLETS FOR HT-1…

Cycle launches COVID-19 Response Program

Given the unprecedented COVID-19 lockdown that shuts down patient access to wellbeing facilities that may seriously…

Don't miss the next Tyrosinemia Connections sessions

Tyrosinemia Connections: A Live Community Event

We are extremely excited to present to you a new monthly educational online community meeting series titled…

Cycle Pharmaceuticals’ Nityr® Supply Chain Update

At Cycle Pharmaceuticals, the health and safety of patients with Hereditary Tyrosinemia Type 1 (HT-1) is our top…

Cycle Pharmaceuticals is pleased to announce that it has signed an agreement with Baylor Genetics

See more
NITYR
Are you a US Healthcare Professional?
NO * YES

* If you select "no" then you will be directed to the Cycle Pharmaceuticals website.

By continuing to use this site you are accepting our cookie policy OK
x OPEN

Sign up for updates

Speciality